|
Body and uterine weight in mice fed soy isoflavones and administered LPS. |
||
| Treatment |
Body wt (g) |
Uterine wt (g) |
|
|
||
| 0 IF Placebo |
19.0 ± 0.3 |
0.12 ± 0.01 |
| 0 IF LPS |
19.6 ± 0.4 |
0.11 ± 0.01 |
| 126 IF Placebo |
19.6 ± 0.2 |
0.12 ± 0.01 |
| 126 IF LPS |
19.4 ± 0.3 |
0.13 ± 0.01 |
| 504 IF Placebo |
19.7 ± 0.3 |
0.11 ± 0.01 |
| 504 IF LPS |
19.7 ± 0.2 |
0.13 ± 0.01 |
| P value |
||
| LPS |
0.4703 |
0.1457 |
| IF |
0.3844 |
0.4305 |
| LPS*IF |
0.3933 |
0.2276 |
|
Mice were fed soy isoflavones (IF; 0, 126 or 504 mg aglycone equivalents of IF/kg diet) for 14-days prior to and during a 30-day exposure to LPS (1.33 μg/d). Results are expressed as means ± standard error. | ||
Droke et al. Journal of Inflammation 2007 4:17 doi:10.1186/1476-9255-4-17 |
||